Evaluation of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting: a prospective multicenter registration study.

Evaluation of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting: a prospective multicenter registration study. - Evaluation of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting: a prospective multicenter registration study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014605

Enrollment

Registered

2014-07-31

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive jaundice

Interventions

EUS guided hepaticogastrostomy nd antegrade stenting

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: # Unresectable malignant disease # Malignant biliary obstruction to be required biliary drainage # Unsuccessful transpapillary drainage and EUS-guided choledochoduodenostomy # Written informed consent # Survival for 3 months or longer

Exclusion criteria

Exclusion criteria: # Iability to perform endoscopy # Performance status = 4 # Serious failure of other organs # Inability to obtain informed consent

Design outcomes

Primary

Measure	Time frame
The stent patency rate 3 months after EUS-HGAS	—

Countries

Japan

Contacts

Public ContactMasayuki Kitano

Kinki University Faculty of Medicine Department of Gastroenterology and Hepatology

m-kitano@med.kindai.ac.jp072-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026